跳至主要内容
临床试验/NCT04606927
NCT04606927已完成不适用

Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure

University Medical Center Groningen2 个研究点 分布在 1 个国家目标入组 310 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
310
试验地点
2
主要终点
Total Natriuresis After 24 Hours

研究概览

简要总结

Administration of loop diuretics to achieve decongestion is the current cornerstone of therapy for acute heart failure. Unfortunately, there is a lack of evidence of how to guide diuretic treatment. Recently, urinary sodium, as a response measure of diuretic response, has been proposed as a target for therapy. The hypothesis of this study is that natriuresis guided therapy in patients with acute heart failure will improve diuretic response, decongestion, and reduce length of hospital stay, as well as heart failure rehospitalisations.

详细描述

Objective: To assess the effect of natriuresis guided therapy in acute heart failure to improve diuretic response, decongestion, and clinical outcomes

Study design: Randomised, controlled, open label study

Study population: 310 patients admitted with the primary diagnosis of acute heart failure requiring intravenous loop diuretics.

Intervention: natriuresis guided treatment versus standard of care

Main study parameters/endpoints:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female ≥ 18 years of age
  • Primary diagnosis of acute /decompensated heart failure as assessed by treating physician
  • a. Acute Heart failure can be de novo or exacerbation of known heart failure and diagnosis is based on criteria in the ESC HF guidelines
  • Requirement of intravenous diuretic use

排除标准

  • Dyspnoea primarily due to non-cardiac causes
  • Patients with severe renal impairment receiving dialysis or requiring ultrafiltration
  • Inability to follow instructions
  • Any other medical conditions that may put the patient at risk or influence study results in the investigator's opinion, or that the investigator deems unsuitable for the study

结局指标

主要结局

Total Natriuresis After 24 Hours

时间窗: 24 hours

The first component of the co-primary end-point is total natriuresis after 24 h (mmol). To assess this, urine is collected for 24 hours after the first administration of diuretics according to the study protocol and natriuresis is calculated as the total amount of diuresis (L) multiplied by the urinary sodium concentration (mmol/L).

First Occurrence of All-cause Mortality or Heart Failure Rehospitalization After 180 Days

时间窗: 180 days

次要结局

  • 48-hours Natriuresis(48 hours)
  • 72-hours Natriuresis(72 hours)
  • Length of Hospital Stay(Variable)
  • Percentage Change in NT-proBNP at 48 Hours(48 hours)
  • Percentage Change in NT-proBNP at 72 Hours(72 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jozine ter Maaten

Principle investigator

University Medical Center Groningen

研究点 (2)

Loading locations...

相似试验